Victrex plc (VCT) Given Consensus Rating of “Hold” by Analysts

Shares of Victrex plc (LON:VCT) have received an average rating of “Hold” from the thirteen research firms that are currently covering the company, MarketBeat reports. Three analysts have rated the stock with a sell rating, six have issued a hold rating and four have given a buy rating to the company. The average 12 month target price among brokers that have covered the stock in the last year is GBX 2,488.75 ($32.52).

Several brokerages have issued reports on VCT. UBS Group restated a “buy” rating and issued a GBX 3,600 ($47.04) price target (up from GBX 3,300 ($43.12)) on shares of Victrex in a report on Thursday, October 4th. Peel Hunt restated an “add” rating on shares of Victrex in a report on Wednesday, July 25th. Barclays restated an “underweight” rating and issued a GBX 2,380 ($31.10) price target (up from GBX 2,300 ($30.05)) on shares of Victrex in a report on Tuesday, July 24th. Liberum Capital restated a “buy” rating and issued a GBX 2,825 ($36.91) price target on shares of Victrex in a report on Wednesday, July 25th. Finally, Morgan Stanley increased their price target on Victrex from GBX 1,600 ($20.91) to GBX 2,980 ($38.94) and gave the stock an “equal weight” rating in a report on Monday, July 16th.

LON VCT opened at GBX 2,720 ($35.54) on Friday. Victrex has a 12 month low of GBX 1,826 ($23.86) and a 12 month high of GBX 2,772 ($36.22).

About Victrex

Victrex plc, through its subsidiaries, manufactures and sells polymers worldwide. It operates through two segments, Victrex Polymer Solutions and Invibio Biomaterial Solutions. The company offers VICTREX PEEK polymer materials; and biomaterial solutions for use in spine, dental, trauma, knee, cardiovascular, and orthopedic applications.

Featured Story: Google Finance Portfolio

Analyst Recommendations for Victrex (LON:VCT)

Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply